May Measurement Month 2018: an analysis of blood pressure screening results from Oman.

Blood pressure Control Hypertension Oman Screening Treatment

Journal

European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647

Informations de publication

Date de publication:
Aug 2020
Historique:
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 5 9 2020
Statut: ppublish

Résumé

As per WHO estimates, around 17% of the adult Omani population are hypertensive. However, people with hypertension are often unaware of the diagnosis, and so the May Measurement Month (MMM) programme was set up to raise awareness of the importance of blood pressure (BP) screening. A cross-sectional screening of BP of subjects aged 18 years or more was carried out in May 2018 at various sites in Muscat, Oman. Screening sites were set up at the reception areas of participating hospitals, and at a few public areas such as shopping malls and workplaces of the volunteers. Blood pressure was measured according to a standardized protocol, and hypertension was defined as per the 2018 European Society of Hypertension guidelines. The data were analysed centrally by the MMM project team. A total of 12 689 individuals (mean age 40.6 ± 12.5 years, 72% male) were screened. The crude mean BP of the second and third readings (where three readings were taken,

Identifiants

pubmed: 32884484
doi: 10.1093/eurheartj/suaa039
pii: suaa039
pmc: PMC7455257
doi:

Types de publication

Journal Article

Langues

eng

Pagination

H100-H103

Informations de copyright

Published on behalf of the European Society of Cardiology. © The Author(s) 2020.

Références

J Hum Hypertens. 2019 Aug;33(8):559-561
pubmed: 31270393
East Mediterr Health J. 1999 Jan;5(1):46-54
pubmed: 10793780
Hypertension. 2002 Nov;40(5):640-6
pubmed: 12411456
Sultan Qaboos Univ Med J. 2013 Feb;13(1):43-50
pubmed: 23573381
J Educ Health Promot. 2018 Oct 29;7:134
pubmed: 30505862
J Hypertens. 2018 Oct;36(10):1953-2041
pubmed: 30234752
JAMA. 2017 Jan 10;317(2):165-182
pubmed: 28097354
Lancet Glob Health. 2018 Jul;6(7):e736-e743
pubmed: 29778399
Sci Rep. 2014 May 02;4:4845
pubmed: 24784167
J Egypt Public Health Assoc. 2015 Sep;90(3):125-32
pubmed: 26544842
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105

Auteurs

Sunil K Nadar (SK)

Department of Medicine, Sultan Qaboos University Hospital, Muscat, 123, Oman.

Hassan Al-Riyami (H)

Department of Medicine, Sultan Qaboos University Hospital, Muscat, 123, Oman.

Adil Al-Riyami (A)

Department of Medicine, Sultan Qaboos University Hospital, Muscat, 123, Oman.

Hatim Al-Lawati (H)

Department of Medicine, Sultan Qaboos University Hospital, Muscat, 123, Oman.

Benny Panakkal (B)

Department of Medicine, Badar Al-Samaa Hospital, Ruwi, Muscat, Oman.

Shafeek Mohammed (S)

Department of Medicine, Badar Al-Samaa Hospital, Ruwi, Muscat, Oman.

G B Nagaraju (GB)

Department of Medicine, Badar Al-Samaa Hospital, Ruwi, Muscat, Oman.

S N Sharma (SN)

Department of Medicine, Badar Al-Samaa Hospital, Ruwi, Muscat, Oman.

Muhamed M Abdulkader (MM)

Department of Medicine, Badar Al-Samaa Hospital, Ruwi, Muscat, Oman.

Thomas Beaney (T)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Department of Primary Care and Public Health, Imperial College London, St Dunstan's Road London W6 8RP, UK.

Anca Chis Ster (AC)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Neil R Poulter (NR)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Classifications MeSH